Donanemab Significantly Slows Progression of Alzheimer’s Disease, Study FindsJul 18, 2023 12:00:00 AM
FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s DiseaseMay 11, 2023 12:00:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
Methylphenidate May Reduce Symptoms of Apathy in Patients With Alzheimer’s DiseaseSep 28, 2021 12:00:00 AM
